Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,988
- Value
- $360.8K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,988 | $360.8K | <0.1% | +3,988 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −3,031−100.0% | Sold out | Holders |
| Q3 2024 | 3,031 | $200.0K | <0.1% | +3,031 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −2,830−100.0% | Sold out | Holders |
| Q4 2023 | 2,830 | $215.8K | <0.1% | +2,830 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −2,889−100.0% | Sold out | Holders |
| Q2 2023 | 2,889 | $272.5K | <0.1% | +42+1.5% | Added | Holders |
| Q1 2023 | 2,847 | $235.5K | <0.1% | −567−16.6% | Reduced | Holders |
| Q4 2022 | 3,414 | $255.0K | <0.1% | −2,986−46.7% | Reduced | Holders |
| Q3 2022 | 6,400 | $529.0K | <0.1% | −584−8.4% | Reduced | Holders |
| Q2 2022 | 6,984 | $664.0K | <0.1% | −482−6.5% | Reduced | Holders |
| Q1 2022 | 7,466 | $879.0K | <0.1% | +416+5.9% | Added | Holders |
| Q4 2021 | 7,050 | $913.0K | <0.1% | +240+3.5% | Added | Holders |
| Q3 2021 | 6,810 | $771.0K | <0.1% | +442+6.9% | Added | Holders |
| Q2 2021 | 6,368 | $660.0K | <0.1% | +3,639+133.3% | Added | Holders |
| Q1 2021 | 2,729 | $228.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.